Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

capsase-9-PP2A interaction inhibitor PEP-010

A cell penetrating and interfering peptide composed of a cell-penetrating part that delivers the peptide into the cellular cytosol and an interfering part that inhibits the interaction between the proteins intracellular caspase-9 and protein phosphatase 2A (PP2A) proteins, with potential antineoplastic activity. Upon administration, the cell-penetrating part of capsase-9-PP2A interaction inhibitor PEP-010 delivers the peptide into the cellular cytosol and the interfering part of PEP-010 disrupts the interaction between intracellular caspase-9 and PP2A. This leads to the release and the activation of caspase-9, thereby restoring tumor cell apoptosis. Activated caspase-9 is involved in the induction of caspase-dependent apoptosis. PP2A, a serine/threonine phosphatase, plays a key role in the control of cell growth and DNA damage repair.
Synonym:cell penetrating and capsase-9/PP2A interaction interfering peptide PEP-010
cell penetrating and interfering peptide PEP-010
Code name:PEP 010
PEP-010
PEP010
Search NCI's Drug Dictionary